Tropical endomyocardial fibrosis
Learn about Tropical endomyocardial fibrosis, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Davies disease; TEMF
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.
What it is
From: Orphanet
Tropical endomyocardial fibrosis is a restrictive cardiopathy, occuring almost exclusively in children and young adults in tropical and subtropical regions, characterized by endocardial fibrosis, affecting the apices and the inflow tract of the right or left ventricle (or both) and manifesting with a restrictive cardiomyopathy and atrioventricular regurgitation leading to severe pulmonary hypertension, very high systemic venous pressure and congestive cardiac failure. Suspected etiologies include helminth and protozoal infestation and malnutrition.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal EKG · Very frequent (99-80%)
- Abnormal rhythm of the heart.
- Dyspnea · Very frequent (99-80%)
- Difficult or labored breathing. Dyspnea is a subjective feeling only the patient can rate, e.g., on a Borg scale.
- Endocardial fibrosis · Obligate (100%)
- The presence of excessive connective tissue in the endocardium.
- Fatigue · Very frequent (99-80%)
- A subjective feeling of tiredness characterized by a lack of energy and motivation.
- Restrictive cardiomyopathy · Very frequent (99-80%)
- Restrictive left ventricular physiology is characterized by a pattern of ventricular filling in which increased stiffness of the myocardium causes ventricular pressure to rise precipitously with only small increases in volume, defined as restrictive ventricular physiology in the presence of normal or reduced diastolic volumes (of one or both ventricles), normal or reduced systolic volumes, and normal ventricular wall thickness.
- Abnormal ST segment · Frequent (79-30%)
- An electrocardiographic anomaly of the ST segment, which is the segment that connects the QRS complex and the T wave. The ST segment normally has a duration of 80 to 120 ms, is flat and at the same level (isoelectric) as the PR and TP segment.
- Arrhythmia · Frequent (79-30%)
- Any cardiac rhythm other than the normal sinus rhythm. Such a rhythm may be either of sinus or ectopic origin and either regular or irregular. An arrhythmia may be due to a disturbance in impulse formation or conduction or both.
- Ascites · Frequent (79-30%)
- Accumulation of fluid in the peritoneal cavity (between the layers of the peritoneum that lines the abdomen).
- Atrioventricular block · Frequent (79-30%)
- Delayed or lack of conduction of atrial depolarizations through the atrioventricular node to the ventricles.
- Cachexia · Frequent (79-30%)
- Severe weight loss, wasting of muscle, loss of appetite, and general debility related to a chronic disease.
- Cardiomegaly · Frequent (79-30%)
- Increased size of the heart, clinically defined as an increased transverse diameter of the cardiac silhouette that is greater than or equal to 50% of the transverse diameter of the chest (increased cardiothoracic ratio) on a posterior-anterior projection of a chest radiograph or a computed tomography.
- Decreased QRS voltage · Frequent (79-30%)
- Reduced amplitude (height) of the QRS complex of the electrocardiogram (EKG), defined as amplitudes of all the QRS complexes in the limb leads are less than 5 mm or amplitudes of all the QRS complexes in the precordial leads less than 10 mm.
- Fever · Frequent (79-30%)
- Body temperature elevated above the normal range.
- Hepatomegaly · Frequent (79-30%)
- Abnormally increased size of the liver.
Other findings in the same source
From: Orphanet
Additional reported features include Hypoalbuminemia (Frequent (79-30%)); Left atrial enlargement (Frequent (79-30%)); Left bundle branch block (Frequent (79-30%)); Left ventricular diastolic dysfunction (Frequent (79-30%)); Malnutrition (Frequent (79-30%)); Orthopnea (Frequent (79-30%)); Peripheral edema (Frequent (79-30%)); Prolonged QRS complex (Frequent (79-30%)); Pulmonary venous hypertension (Frequent (79-30%)); Quadruple gallop rhythm (Frequent (79-30%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Adolescent; Adult; Childhood
Inheritance in the source
From: Orphanet
Not applicable
Frequency and the population described
From: Orphanet
Point prevalence: Unknown; Worldwide; Class only.
Which doctor should you see?
The suggested department for discussing Tropical endomyocardial fibrosis is Cardiology, with a cardiologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Is the main concern heart structure, rhythm, circulation or another cause?
- Which symptoms should change the timing of follow-up?
- How would a proposed investigation change the care plan?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Tropical endomyocardial fibrosis. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by a cardiologist. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Tropical endomyocardial fibrosis — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-2362.